{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T18:55:42Z","timestamp":1790362542282,"version":"4.1.0"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003407","name":"Ministero dell\u2019Istruzione, dell\u2019Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003407","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005969","name":"Universit\u00e0 di Bologna","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005969","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2018,7]]},"DOI":"10.1016\/j.ejmech.2018.06.044","type":"journal-article","created":{"date-parts":[[2018,6,19]],"date-time":"2018-06-19T18:53:19Z","timestamp":1529434399000},"page":"839-846","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":49,"special_numbering":"C","title":["Tacripyrimidines, the first tacrine-dihydropyrimidine hybrids, as multi-target-directed ligands for Alzheimer's disease"],"prefix":"10.1016","volume":"155","author":[{"given":"Mourad","family":"Chioua","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleonora","family":"Buzzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ignacio","family":"Moraleda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabel","family":"Iriepa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maciej","family":"Maj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Artur","family":"Wnorowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catia","family":"Giovannini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Tramarin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federica","family":"Portali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6013-3150","authenticated-orcid":false,"given":"Lhassane","family":"Ismaili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pilar","family":"L\u00f3pez-Alvarado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1289-5361","authenticated-orcid":false,"given":"Maria Laura","family":"Bolognesi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krzysztof","family":"J\u00f3\u017awiak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0560-8416","authenticated-orcid":false,"given":"J. Carlos","family":"Men\u00e9ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9","family":"Marco-Contelles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2890-3856","authenticated-orcid":false,"given":"Manuela","family":"Bartolini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2018.06.044_bib1","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1126\/science.1132814","article-title":"A\u00a0century of Alzheimer's disease","volume":"314","author":"Goedert","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.ejmech.2018.06.044_bib2","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1016\/S0047-6374(01)00309-8","article-title":"Acetylcholinesterase in Alzheimer's disease","volume":"122","author":"Talesa","year":"2001","journal-title":"Mech. Ageing Dev."},{"key":"10.1016\/j.ejmech.2018.06.044_bib3","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.phrs.2003.12.027","article-title":"Acetylcholinesterase inhibitors: novel activities of old molecules","volume":"50","author":"Racchi","year":"2004","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.ejmech.2018.06.044_bib4","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1586\/14737175.8.11.1703","article-title":"Cholinergic system during the progression of Alzheimer's disease: therapeutic implications","volume":"8","author":"Mufson","year":"2008","journal-title":"Expert Rev. Neurother."},{"key":"10.1016\/j.ejmech.2018.06.044_bib5","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/S0896-6273(00)80108-7","article-title":"Acetylcholinesterase accelerates assembly of amyloid-beta-peptides into Alzheimer's fibrils: possible role of the peripheral site of the enzyme","volume":"16","author":"Inestrosa","year":"1996","journal-title":"Neuron"},{"key":"10.1016\/j.ejmech.2018.06.044_bib6","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/S0006-2952(02)01514-9","article-title":"beta-Amyloid aggregation induced by human acetylcholinesterase: inhibition studies","volume":"65","author":"Bartolini","year":"2003","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejmech.2018.06.044_bib7","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.trci.2017.05.002","article-title":"Alzheimer's disease drug development pipeline: 2017","volume":"3","author":"Cummings","year":"2017","journal-title":"Alzheimers Dement (N Y)"},{"key":"10.1016\/j.ejmech.2018.06.044_bib8","doi-asserted-by":"crossref","first-page":"995","DOI":"10.4155\/fmc-2017-0038","article-title":"Neuroregeneration versus neurodegeneration: toward a paradigm shift in Alzheimer's disease drug discovery","volume":"9","author":"Uliassi","year":"2017","journal-title":"Future Med. Chem."},{"key":"10.1016\/j.ejmech.2018.06.044_bib9","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1021\/jm7009364","article-title":"Multi-target-Directed ligands to combat neurodegenerative diseases","volume":"51","author":"Cavalli","year":"2008","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2018.06.044_bib10","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1002\/med.20248","article-title":"Recent advances in the multitarget-directed ligands approach for the treatment of Alzheimer's disease","volume":"33","author":"Le\u00f3n","year":"2013","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.ejmech.2018.06.044_bib11","doi-asserted-by":"crossref","first-page":"466","DOI":"10.3390\/molecules21040466","article-title":"Navigating the chemical space of multitarget-directed ligands: from hybrids to fragments in Alzheimer's disease","volume":"21","author":"Prati","year":"2016","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2018.06.044_bib12","doi-asserted-by":"crossref","first-page":"697","DOI":"10.4155\/fmc-2016-0003","article-title":"Multitarget strategies in Alzheimer's disease: benefits and challenges on the road to therapeutics","volume":"8","author":"Rosini","year":"2016","journal-title":"Future Med. Chem."},{"key":"10.1016\/j.ejmech.2018.06.044_bib13","doi-asserted-by":"crossref","first-page":"205","DOI":"10.3389\/fnins.2016.00205","article-title":"Multi-target directed donepezil-like ligands for Alzheimer's disease","volume":"10","author":"Unzeta","year":"2016","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.ejmech.2018.06.044_bib14","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.ejmech.2016.10.060","article-title":"A\u00a0review on tacrine-based scaffolds as multi-target drugs (MTDLs) for Alzheimer's disease","volume":"128","author":"Sameem","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.06.044_bib15","doi-asserted-by":"crossref","first-page":"3000","DOI":"10.2174\/1568026617666170717114944","article-title":"Therapeutic agents in Alzheimer's disease through a multi-target directed ligands strategy: recent progress based on tacrine core","volume":"17","author":"Lin","year":"2017","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.06.044_bib16","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.pneurobio.2015.12.003","article-title":"Multitarget compounds bearing tacrine- and donepezil-like structural and functional motifs for the potential treatment of Alzheimer's disease","volume":"151","author":"Ismaili","year":"2017","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.ejmech.2018.06.044_bib17","doi-asserted-by":"crossref","first-page":"373","DOI":"10.2174\/0929867321666141106122628","article-title":"Recent development of multifunctional agents as potential drug candidates for the treatment of Alzheimer's disease","volume":"22","author":"Guzior","year":"2015","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.06.044_bib18","doi-asserted-by":"crossref","first-page":"7607","DOI":"10.1021\/jm061047j","article-title":"Novel multipotent tacrine-dihydropyridine hybrids with improved acetylcholinesterase inhibitory and neuroprotective activities as potential drugs for the treatment of Alzheimer's disease","volume":"49","author":"Marco-Contelles","year":"2006","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2018.06.044_bib19","doi-asserted-by":"crossref","first-page":"2724","DOI":"10.1021\/jm801292b","article-title":"Tacripyrines, the first tacrine-dihydropyridine hybrids, as multitarget-directed ligands for the treatment of Alzheimer's disease","volume":"52","author":"Marco-Contelles","year":"2009","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2018.06.044_bib20","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1002\/cmdc.201100239","article-title":"Chemical and pharmacological studies on enantiomerically pure p-methoxytacripyrines, promising multi-target-directed ligands for the treatment of Alzheimer's disease","volume":"6","author":"Bartolini","year":"2011","journal-title":"ChemMedChem"},{"key":"10.1016\/j.ejmech.2018.06.044_bib21","doi-asserted-by":"crossref","first-page":"39695","DOI":"10.1074\/jbc.M102334200","article-title":"Calcium entry through L-type calcium channels causes mitochondrial disruption and chromaffin cell death","volume":"276","author":"Cano-Abad","year":"2001","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ejmech.2018.06.044_bib22","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1089\/ars.2010.3359","article-title":"Calcium dysregulation and homeostasis of neural calcium in the molecular mechanisms of neurodegenerative diseases provide multiple targets for neuroprotection","volume":"14","author":"Zundorf","year":"2011","journal-title":"Antioxidants Redox Signal."},{"key":"10.1016\/j.ejmech.2018.06.044_bib23","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0306-4522(02)00912-0","article-title":"Combined nimodipine and citicoline reduce infarct size, attenuate apoptosis and increase bcl-2 expression after focal cerebral ischemia","volume":"118","author":"Sobrado","year":"2003","journal-title":"Neuroscience"},{"key":"10.1016\/j.ejmech.2018.06.044_bib24","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1111\/bph.12240","article-title":"Calcium channel blockers and dementia","volume":"169","author":"Nimmrich","year":"2013","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejmech.2018.06.044_bib25","doi-asserted-by":"crossref","first-page":"49","DOI":"10.3233\/JAD-2009-0925","article-title":"Identification of antihypertensive drugs which inhibit amyloid-beta protein oligomerization","volume":"16","author":"Zhao","year":"2009","journal-title":"J\u00a0Alzheimers Dis"},{"key":"10.1016\/j.ejmech.2018.06.044_bib26","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.nbd.2010.08.020","article-title":"L-type voltage-gated calcium channel blockade with isradipine as a therapeutic strategy for Alzheimer's disease","volume":"41","author":"Anekonda","year":"2011","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.ejmech.2018.06.044_bib27","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1248\/bpb.30.698","article-title":"Nilvadipine prevents the impairment of spatial memory induced by cerebral ischemia combined with beta-amyloid in rats","volume":"30","author":"Iwasaki","year":"2007","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.ejmech.2018.06.044_bib28","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1021\/jm00106a048","article-title":"Dihydropyrimidine calcium channel blockers. 3. 3-Carbamoyl-4-aryl-1,2,3,4-tetrahydro-6-methyl-5-pyrimidinecarboxylic acid esters as orally effective antihypertensive agents","volume":"34","author":"Atwal","year":"1991","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2018.06.044_bib29","doi-asserted-by":"crossref","first-page":"8582","DOI":"10.1016\/j.bmc.2006.08.031","article-title":"Synthesis of 4-aryl-3,4-dihydropyrimidin-2(1H)-thione derivatives as potential calcium channel blockers","volume":"14","author":"Zorkun","year":"2006","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.06.044_bib30","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1021\/acschemneuro.7b00187","article-title":"To target beta-amyloid cellular pathologies through a metal-dependent mechanism","volume":"8","author":"Tardiff","year":"2017","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.ejmech.2018.06.044_bib31","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1001\/jama.1994.03510370044030","article-title":"Hepatotoxic effects of tacrine administration in patients with Alzheimer's disease","volume":"271","author":"Watkins","year":"1994","journal-title":"J.\u00a0Am. Med. Assoc."},{"key":"10.1016\/j.ejmech.2018.06.044_bib32","first-page":"37","article-title":"The friedl\u00e4nder synthesis of quinolines","volume":"28","author":"Cheng","year":"1982","journal-title":"Org. React."},{"key":"10.1016\/j.ejmech.2018.06.044_bib33","doi-asserted-by":"crossref","first-page":"2652","DOI":"10.1021\/cr800482c","article-title":"Recent advances in the Friedlander reaction","volume":"109","author":"Marco-Contelles","year":"2009","journal-title":"Chem. Rev."},{"key":"10.1016\/j.ejmech.2018.06.044_bib34","series-title":"The Friedl\u00e4nder Reaction","author":"Marco-Contelles","year":"2010"},{"key":"10.1016\/j.ejmech.2018.06.044_bib35","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1080\/10426507.2013.818995","article-title":"An efficient one-pot synthesis of new 2- thioxo and 2-oxo-pyrimidine-5-carbonitriles in ball-milling under solvent-free and catalyst-free conditions, phosphorus","volume":"189","author":"M\u2019hamed","year":"2014","journal-title":"Sulfur, Silicon Relat. Elem."},{"key":"10.1016\/j.ejmech.2018.06.044_bib36","doi-asserted-by":"crossref","first-page":"5135","DOI":"10.1016\/j.tetlet.2016.09.047","article-title":"Biginelli reaction: an overview","volume":"57","author":"Nagarajaiah","year":"2016","journal-title":"Tetrahedron Lett."},{"key":"10.1016\/j.ejmech.2018.06.044_bib37","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/0006-2952(61)90145-9","article-title":"A\u00a0new and rapid colorimetric determination of acetylcholinesterase activity","volume":"7","author":"Ellman","year":"1961","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejmech.2018.06.044_bib38","article-title":"A\u00a0review of butyrylcholinesterase as a therapeutic target in the treatment of Alzheimer's disease","volume":"15","author":"Nordberg","year":"2013","journal-title":"Prim. Care Companion. CNS Disord."},{"key":"10.1016\/j.ejmech.2018.06.044_bib39","doi-asserted-by":"crossref","first-page":"7683","DOI":"10.1021\/acs.jmedchem.6b00356","article-title":"Discovery and structure-activity relationships of a highly selective butyrylcholinesterase inhibitor by structure-based virtual screening","volume":"59","author":"Dighe","year":"2016","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2018.06.044_bib40","doi-asserted-by":"crossref","first-page":"8167","DOI":"10.1021\/jm501195e","article-title":"Discovery, biological evaluation, and crystal structure of a novel nanomolar selective butyrylcholinesterase inhibitor","volume":"57","author":"Brus","year":"2014","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2018.06.044_bib41","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/jcc.21334","article-title":"AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading","volume":"31","author":"Trott","year":"2010","journal-title":"J.\u00a0Comput. Chem."},{"key":"10.1016\/j.ejmech.2018.06.044_bib42","doi-asserted-by":"crossref","first-page":"6119","DOI":"10.1016\/j.ejmech.2011.09.038","article-title":"Synthesis and biological assessment of diversely substituted furo[2,3-b]quinolin-4-amine and pyrrolo[2,3-b]quinolin-4-amine derivatives, as novel tacrine analogues","volume":"46","author":"Martins","year":"2011","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.06.044_bib43","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1021\/acs.jmedchem.5b01119","article-title":"Novel tacrine-benzofuran hybrids as potent multitarget-directed ligands for the treatment of Alzheimer's disease: design, synthesis, biological evaluation, and x-ray crystallography","volume":"59","author":"Zha","year":"2016","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2018.06.044_bib44","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1002\/cbic.200700427","article-title":"Insight into the kinetic of amyloid beta (1-42) peptide self-aggregation: elucidation of inhibitors' mechanism of action","volume":"8","author":"Bartolini","year":"2007","journal-title":"Chembiochem"},{"key":"10.1016\/j.ejmech.2018.06.044_bib45","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.ab.2011.03.020","article-title":"Kinetic characterization of amyloid-beta 1-42 aggregation with a multimethodological approach","volume":"414","author":"Bartolini","year":"2011","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.ejmech.2018.06.044_bib46","first-page":"1132","article-title":"Screening of hepatoprotective plant components using a HepG2 cell cytotoxicity assay","volume":"11","author":"Thabrew","year":"1977","journal-title":"J.\u00a0Pharm. Pharmacol."},{"key":"10.1016\/j.ejmech.2018.06.044_bib47","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/j.chembiol.2014.08.013","article-title":"Oral druggable space beyond the rule of 5: insights from drugs and clinical candidates","volume":"21","author":"Doak","year":"2014","journal-title":"Chem. Biol."},{"key":"10.1016\/j.ejmech.2018.06.044_bib48","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0169-409X(00)00129-0","article-title":"Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings","volume":"46","author":"Lipinski","year":"2001","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejmech.2018.06.044_bib49","doi-asserted-by":"crossref","first-page":"2878","DOI":"10.1021\/ja993663t","article-title":"Prediction of properties from simulations: free energies of solvation in hexadecane, octanol, and water","volume":"122","author":"Duffy","year":"2000","journal-title":"J.\u00a0Am. Chem. Soc."},{"key":"10.1016\/j.ejmech.2018.06.044_bib50","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1016\/S0960-894X(00)00172-4","article-title":"Prediction of drug solubility from Monte Carlo simulations","volume":"10","author":"Jorgensen","year":"2000","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2018.06.044_bib51","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1007\/s00213-015-4133-5","article-title":"A\u00a0novel acetylcholinesterase inhibitor and calcium channel blocker SCR-1693 improves A\u03b225\u201335-impaired mouse cognitive function","volume":"223","author":"Zhang","year":"2016","journal-title":"Psychopharmacology"},{"issue":"Suppl 1","key":"10.1016\/j.ejmech.2018.06.044_bib52","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1017\/S1041610203008676","article-title":"Butyrylcholinesterase: an important new target in Alzheimer's disease therapy","volume":"14","author":"Greig","year":"2002","journal-title":"Int. Psychogeriatr."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S022352341830535X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S022352341830535X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T13:46:05Z","timestamp":1759326365000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S022352341830535X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7]]},"references-count":52,"alternative-id":["S022352341830535X"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2018.06.044","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2018,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tacripyrimidines, the first tacrine-dihydropyrimidine hybrids, as multi-target-directed ligands for Alzheimer's disease","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2018.06.044","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}